Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) SVP Emily Dreyer sold 3,100 shares of the business’s stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $54.85, for a total transaction of $170,035.00. Following the transaction, the senior vice president now owns 24,708 shares of the company’s stock, valued at approximately $1,355,233.80. This represents a 11.15 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Emily Dreyer also recently made the following trade(s):
- On Monday, November 25th, Emily Dreyer sold 900 shares of Trupanion stock. The shares were sold at an average price of $54.55, for a total value of $49,095.00.
Trupanion Trading Down 1.6 %
TRUP opened at $53.50 on Thursday. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The company’s 50 day moving average price is $49.50 and its two-hundred day moving average price is $39.97. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of -167.19 and a beta of 1.69.
Institutional Investors Weigh In On Trupanion
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Quest Partners LLC bought a new stake in Trupanion in the third quarter valued at approximately $37,000. Wilmington Savings Fund Society FSB acquired a new position in shares of Trupanion in the 3rd quarter worth approximately $54,000. GAMMA Investing LLC lifted its position in shares of Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after purchasing an additional 596 shares during the period. Headlands Technologies LLC bought a new stake in shares of Trupanion in the 2nd quarter valued at $162,000. Finally, Entropy Technologies LP acquired a new stake in shares of Trupanion during the third quarter worth $202,000.
Wall Street Analyst Weigh In
Several research firms recently weighed in on TRUP. Evercore ISI raised Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Stifel Nicolaus raised their price target on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Bank of America upped their price objective on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Northland Securities increased their price objective on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Finally, Piper Sandler boosted their target price on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $44.67.
View Our Latest Stock Report on Trupanion
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- 3 Warren Buffett Stocks to Buy Now
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Are Penny Stocks a Good Fit for Your Portfolio?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Most active stocks: Dollar volume vs share volume
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.